| P2093 | author name string | Basileios-Georgiou Spyropoulos | |
| | Christos-Nikolaou Stoidis | |
| | Constantine-Iosif Fotiadis | |
| | Eleftherios-Dimitriou Zografos | |
| P2860 | cites work | Probiotics in human medicine | Q24540394 |
| | Does butyrate protect from colorectal cancer? | Q28295747 |
| | Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics | Q28303404 |
| | Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon | Q31835299 |
| | Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data | Q33214751 |
| | Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. | Q33786301 |
| | Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria | Q33957357 |
| | The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans | Q34486626 |
| | Probiotics in man and animals | Q34505006 |
| | Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? | Q34565686 |
| | Fermented dairy products, calcium, and colorectal cancer in The Netherlands Cohort Study. | Q34728119 |
| | The effects of probiotics on colon cancer development | Q34903381 |
| | Degradation of N-nitrosamines by intestinal bacteria | Q35794595 |
| | Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. | Q35823937 |
| | Recent hypotheses for the origin of colon cancer | Q39662002 |
| | Role of dietary lactobacilli in gastrointestinal microecology | Q40217718 |
| | Distinct immune response induced by peptidoglycan derived from Lactobacillus sp | Q40328255 |
| | Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker's yeast, in vitro | Q40427459 |
| | Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae, the baker's yeast, in vitro | Q40531682 |
| | Influence of methodologic factors in a pooled analysis of 13 case-control studies of colorectal cancer and dietary fiber | Q40719631 |
| | Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line | Q41139183 |
| | Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation | Q41372316 |
| | Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides | Q42249220 |
| | Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. | Q42830585 |
| | Effects of lactic acid bacteria on the uptake and distribution of the food mutagen Trp-P-2 in mice | Q43885018 |
| | The influence of specific luminal factors on the colonic epithelium: high-dose butyrate and physical changes suppress early carcinogenic events in rats. | Q45265617 |
| | Immunomodulation by treatment with Lactobacillus casei strain Shirota | Q46787270 |
| | In vitro binding of potent mutagenic pyrolysates to intestinal bacteria | Q50203192 |
| | A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. | Q52496298 |
| | Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. | Q53362252 |
| | Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. | Q53436505 |
| | Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. | Q53445762 |
| | Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. | Q53478150 |
| | A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. | Q53622567 |
| | Probiotics | Q57241205 |
| | Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon | Q57552167 |
| | Effect of lactobacillus acidophilus and bifidobacterium bifidum on rectal cell kinetics and fecal pH | Q67760999 |
| | Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans | Q68356512 |
| | The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity | Q70473463 |
| | Effect of dairy products on initiation of precursor lesions of colon cancer in rats | Q70958756 |
| | Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes | Q71493611 |
| | Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats | Q71763956 |
| | The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects | Q73888636 |
| | Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran) | Q81057305 |
| | Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice | Q81550884 |
| | Advances in the treatment of metastatic colorectal cancer | Q82040616 |
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| | probiotics | Q1816730 |
| P304 | page(s) | 6453-6457 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer | |
| P478 | volume | 14 | |